n-bromoacetyl-4-azido-l-phenylalanine methyl ester has been researched along with Pregnancy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghababaie, A; Zeina, M | 1 |
| Battersby, C; Harnden, F; Lanoue, J; Modi, N; Uthaya, SN | 1 |
| Arasu, A; Arattu Thodika, FMS; Chapman-Hatchett, N; Chittenden, N; Dassios, T; Greenough, A; Harris, C; Johnson, K; Williams, EE | 1 |
| Fox, GF | 1 |
| Mactier, H | 1 |
| Crowley, N; Fox, GF | 1 |
3 review(s) available for n-bromoacetyl-4-azido-l-phenylalanine methyl ester and Pregnancy
| Article | Year |
|---|---|
Controversies and discussion of the BAPM Framework for the perinatal management of extreme preterm birth before 27 weeks of gestation.
Topics: Azides; Female; Humans; Infant, Newborn; Infant, Premature; Perinatal Care; Pregnancy; Premature Birth | 2021 |
Perspective from the chair of the BAPM Working Group on perinatal management of extreme preterm birth before 27 weeks of gestation.
Topics: Azides; Female; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Perinatal Care; Pregnancy; Premature Birth | 2021 |
Review of the new BAPM framework for practice (2019): Perinatal management of extreme preterm birth before 27 weeks of gestation.
Topics: Azides; Female; Humans; Infant, Newborn; Infant, Premature; Pregnancy; Premature Birth | 2021 |
3 other study(ies) available for n-bromoacetyl-4-azido-l-phenylalanine methyl ester and Pregnancy
| Article | Year |
|---|---|
Assessing risks at 22-24 weeks gestation.
Topics: Female; Gestational Age; Humans; Infant, Extremely Premature; Infant, Newborn; Pregnancy; Resuscitation | 2023 |
Data-driven approach to understanding neonatal palliative care needs in England and Wales: a population-based study 2015-2020.
Topics: England; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Palliative Care; Pregnancy; Wales | 2023 |
Risk assessment of survival and morbidity of infants born at <24 completed weeks of gestation.
Topics: Azides; Female; Humans; Infant; Infant, Newborn; Morbidity; Pregnancy; Retrospective Studies; Risk Assessment | 2023 |